{"DataElement":{"publicId":"7069581","version":"1","preferredName":"CHGB Gene Expression Immunohistochemistry Staining Method Outcome Value","preferredDefinition":"The numeric response that indicates the quantity of Chromogranin B in ng/ml.","longName":"CHGB_PROT_IHC_OUT_VAL","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"7069560","version":"1","preferredName":"CHGB Gene Protein Expression Immunohistochemistry Staining Method Outcome","preferredDefinition":"Encodes Chromogranin B, a tyrosine-sulfated secretory protein found in a wide variety of peptidergic endocrine cells.  Chromogranin functions as a neuroendocrine secretory granule protein which may be the precursor for other biologically active peptides. (LocusLink)_The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus._Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen._The result of an action.","longName":"7069558v1.0:6689825v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"7069558","version":"1","preferredName":"CHGB Gene","preferredDefinition":"Encodes Chromogranin B, a tyrosine-sulfated secretory protein found in a wide variety of peptidergic endocrine cells.  Chromogranin functions as a neuroendocrine secretory granule protein which may be the precursor for other biologically active peptides. (LocusLink)","longName":"C21201","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CHGB Gene","conceptCode":"C21201","definition":"Encodes Chromogranin B, a tyrosine-sulfated secretory protein found in a wide variety of peptidergic endocrine cells.  Chromogranin functions as a neuroendocrine secretory granule protein which may be the precursor for other biologically active peptides. (LocusLink)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"98C157C5-159D-7FCA-E053-F662850A41AC","latestVersionIndicator":"Yes","beginDate":"2019-12-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-02","modifiedBy":"ONEDATA","dateModified":"2019-12-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6689825","version":"1","preferredName":"Protein Expression Immunohistochemistry Staining Method Outcome","preferredDefinition":"The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.:Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.:The result of an action.","longName":"C18966:C23020:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protein Expression","conceptCode":"C18966","definition":"The biosynthesis of new (often sets of distinct, functionally related) protein products, usually involving new mRNA transcripts, typically in response to an activating stimulus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8634324A-14E6-4053-E053-F662850A30A2","latestVersionIndicator":"Yes","beginDate":"2019-04-10","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-04-10","modifiedBy":"ONEDATA","dateModified":"2019-04-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"98C157C5-15AB-7FCA-E053-F662850A41AC","latestVersionIndicator":"Yes","beginDate":"2019-12-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-02","modifiedBy":"HARTLEYG","dateModified":"2019-12-04","changeDescription":"Curated to support Neuroendocrine content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7069551","version":"1","preferredName":"Chromogranin B Lab Value","preferredDefinition":"the numerical quantity measured in a laboratory of Chromogranin A in ng per ml.","longName":"7069551v1.0","context":"OCG","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","unitOfMeasure":"ng/ml","minLength":null,"maxLength":"6","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2414933","version":"1","preferredName":"Value","preferredDefinition":"A numerical quantity measured or assigned or computed.","longName":"C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"02772734-9BE5-6ADF-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-06","modifiedBy":"ONEDATA","dateModified":"2005-10-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"98C157C5-1549-7FCA-E053-F662850A41AC","latestVersionIndicator":"Yes","beginDate":"2019-12-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-02","modifiedBy":"HARTLEYG","dateModified":"2019-12-04","changeDescription":"Curated to support Neuroendocrine content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000177","version":"1","longName":"Neuroendocrine","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Chromogranin B value","type":"Preferred Question Text","description":"Chromogranin B value","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"98C2221F-0526-6947-E053-F662850A38B2","latestVersionIndicator":"Yes","beginDate":"2019-12-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-02","modifiedBy":"HARTLEYG","dateModified":"2019-12-04","changeDescription":"Curated to support Neuroendocrine content_ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}